Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Price

Showing results (151-160 of 260) with videos related to

Pageof 26
Sort By:
Journal of the American College of Cardiology|August 28, 2024
Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage OcclusionSamuel W Reinhardt, Douglas N Gibson, Jonathan C Hsu, et al.
JACC. Cardiovascular Interventions|March 10, 2026
Safety and Effectiveness of a Novel 2Hz Coronary IVL System: The Disrupt CAD Duo IDE StudyRhian E Davies, Richard A Shlofmitz, Michael Kim, et al.
JACC. Cardiovascular Interventions|March 15, 2023
Contemporary Outcomes Following Transcatheter Edge-to-Edge Repair: 1-Year Results From the EXPAND StudySaibal Kar, Ralph Stephan von Bardeleben, Wolfgang Rottbauer, et al.
JACC. Cardiovascular Interventions|March 6, 2025
Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease: 1-Year Results From EXPANDedSaibal Kar, Matthew J Price, M Andrew Morse, et al.
European Heart Journal|September 12, 2018
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trialGregg W Stone, Philippe Généreux, Robert A Harrington, et al.
Journal of the American College of Cardiology|September 4, 2016
"Off-Hours" Versus "On-Hours" Presentation in ST-Segment Elevation Myocardial Infarction: CHAMPION PHOENIX FindingsSenthil Selvaraj, Deepak L Bhatt, Gregg W Stone, et al.
International Journal of Cardiology|October 15, 2017
Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trialsAlon Eisen, Robert A Harrington, Gregg W Stone, et al.
JACC. Clinical Electrophysiology|October 13, 2023
Intracardiac vs Transesophageal Echocardiography for Left Atrial Appendage Occlusion With Watchman FLX in the U.SEnrico G Ferro, Mohamad Alkhouli, Devi G Nair, et al.
JACC. Cardiovascular Interventions|June 28, 2023
Real-World Outcomes of Fourth-Generation Mitral Transcatheter Repair: 30-Day Results From EXPAND G4Ralph Stephan von Bardeleben, Jason H Rogers, Paul Mahoney, et al.
Circulation. Cardiovascular Interventions|June 18, 2016
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX TrialMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Pageof 26

Showing results (151-160 of 260) with videos related to

Sort By:
Pageof 26
Journal of the American College of Cardiology|August 28, 2024
Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage OcclusionSamuel W Reinhardt, Douglas N Gibson, Jonathan C Hsu, et al.
JACC. Cardiovascular Interventions|March 10, 2026
Safety and Effectiveness of a Novel 2Hz Coronary IVL System: The Disrupt CAD Duo IDE StudyRhian E Davies, Richard A Shlofmitz, Michael Kim, et al.
JACC. Cardiovascular Interventions|March 15, 2023
Contemporary Outcomes Following Transcatheter Edge-to-Edge Repair: 1-Year Results From the EXPAND StudySaibal Kar, Ralph Stephan von Bardeleben, Wolfgang Rottbauer, et al.
JACC. Cardiovascular Interventions|March 6, 2025
Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease: 1-Year Results From EXPANDedSaibal Kar, Matthew J Price, M Andrew Morse, et al.
European Heart Journal|September 12, 2018
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trialGregg W Stone, Philippe Généreux, Robert A Harrington, et al.
Journal of the American College of Cardiology|September 4, 2016
"Off-Hours" Versus "On-Hours" Presentation in ST-Segment Elevation Myocardial Infarction: CHAMPION PHOENIX FindingsSenthil Selvaraj, Deepak L Bhatt, Gregg W Stone, et al.
International Journal of Cardiology|October 15, 2017
Cangrelor compared with clopidogrel in patients with prior myocardial infarction - Insights from the CHAMPION trialsAlon Eisen, Robert A Harrington, Gregg W Stone, et al.
JACC. Clinical Electrophysiology|October 13, 2023
Intracardiac vs Transesophageal Echocardiography for Left Atrial Appendage Occlusion With Watchman FLX in the U.SEnrico G Ferro, Mohamad Alkhouli, Devi G Nair, et al.
JACC. Cardiovascular Interventions|June 28, 2023
Real-World Outcomes of Fourth-Generation Mitral Transcatheter Repair: 30-Day Results From EXPAND G4Ralph Stephan von Bardeleben, Jason H Rogers, Paul Mahoney, et al.
Circulation. Cardiovascular Interventions|June 18, 2016
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX TrialMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
Pageof 26